CNP three-lens brief
Evidence-based stock research on CNP. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 16.4pp over 30 days. · Negative free cash flow last quarterly (-$4.95B).
- Underperforming SPY by 16.4pp over 30 days.
- Negative free cash flow last quarterly (-$4.95B).
- Debt-to-equity of 215.6 — balance-sheet-heavy.
CNP closed at $41.85 (-0.66%) as of 2026-05-13. Market cap: $27.38B. P/E (trailing) 25.7. Concerns: underperforming SPY by 16.4pp over 30 days.; negative free cash flow last quarterly (-$4.95B).. Last quarter: Revenue $2.98B, net income $316.00M, free cash flow -$4.95B.
Why three lenses on CNP, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CNPacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CNP" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CNP brief"></iframe>